Immunological effects of IL-21 on T, B and natural killer (NK) cells have been reported, but the role of IL-21 in GVHD remains obscure. Here, we demonstrate that morbidity and mortality of GVHD was significantly reduced after BMT with splenocytes from IL-21R À/À mice compared with those from wild type mice. To further confirm our observation, we generated a decoy receptor for IL-21. GVHD was again less severe in mice receiving BM cells transduced with the IL-21 decoy receptor than control mice These results suggest that IL-21 critically regulates GVHD, and that blockade of the IL-21 signal may represent a novel strategy for the prophylaxis for GVHD.
Introduction
Interleukin (IL)-21 is a member of the common cytokine receptor gamma chain (g c ) family that also includes IL-2, IL-4, IL-7, IL-9 and IL-15. The receptors for each of these cytokines are composed of more specific chain(s) and a g c chain.
1,2 The lack of functional g c causes X-linked SCID disease (X-SCID) in humans, 3 which is characterized by a reduced number of T cells and natural killer (NK) cells, and a normal number but non-functional B cells. The phenotypes of IL-7 and IL-15 knockout (KO) mice suggest that the reduced number of T and NK cells is because of the lack of IL-7 and IL-15 signaling, respectively. 4, 5 We previously proposed that the non-functionality of B cells might be attributed to the lack of both IL-4 and IL-21, based on the observation that IL-4 and IL-21R double KO mice exhibit a B-cell phenotype similar to that found in X-linked SCID disease. 6 The switch from IgM to IgG was impaired but still present in IL-21R À/À mice. 6 IL-21 was cloned as a co-stimulatory cytokine for T-cell proliferation and NK-cell expansion in vitro. 7 IL-21 is primarily produced by CD4 T cells, 7 and the receptor is primarily expressed on T, B and NK cells. 7, 8 It has been reported that IL-21 suppresses the function of DCs 9 and increases the number of hematopoietic progenitor cells. 10 IL-21 has been shown to have critical roles in Ig production. 6 IL-21 is not required, but promotes Th17 differentiation in the presence of transforming growth factor (TGF)-b, [11] [12] [13] whereas reports have differed regarding its contributions to Th1-and Th2-differentiation. 6, [14] [15] [16] [17] Evidence for a relationship between IL-21 and autoimmune disease has been accumulating. For example, overexpression of IL-21 induces inflammation, and in the BXSB.6-Yaa þ /J mouse, a model of systemic lupus erythematosus, affected mice have high levels of IL-21, 18 whereas IL-21R
À/À BXSB.6-Yaa þ /J mice no longer develop systemic lupus erythematosus. 19 In addition, IL-21R À/À NOD mice are resistant to the development of diabetes mellitus. 20, 21 Graft-versus-host disease is a serious complication after hematopoietic SCT. 22 Severe GVHD is difficult to treat because of refractory characteristics and infectious complications resulting from immunosuppressive treatment.
Here, we have investigated the function of IL-21 in GVHD and demonstrate that IL-21 is critical for GVHD, and that blockade of the IL-21 signal could lead to a treatment or prophylaxis for GVHD.
Methods

Mice
Interleukin-21R
À/À (KO) mice were generated previously. 6 Balb/c mice were purchased from Clea Japan (Tokyo, Japan). Perforin-deficient mice and FasL deficient (gld/gld) mice were purchased from Taconic (Hudson, NY, USA) and Japan SLC (Shizuoka, Japan), respectively. All mice were housed in our mouse facility, which is regulated by an intramural small animal committee, and were treated in accordance with the guidelines of Jichi Medical University.
Mouse models of GVHD and GVL Clinical symptoms of GVHD were scored as previously reported.
23
GVHD group 1 (WT-BM and KO-SP vs WT-BM and WT-SP): Balb/c mice were irradiated with 8 Gy and injected intravenously with 5 Â 10 6 wild type (WT)-BM and 5 Â 10 6 splenocytes (SPs) from either WT or KO mice. GVHD group 2 (KO-BM and KO-SP vs KO-BM and WT-SP): To delete the contaminated WT T cells in BM, we used KO-BM.
Flow cytometric analysis
Fc-block (BD Biosciences-Pharmingen, San Diego, CA, USA) was used to prevent non-specific Ab binding to Fc receptors. Anti-CD4, CD8, H-2 b and H-2 d Abs were purchased from BD Biosciences-Pharmingen. A LSR flow cytometer (BD Biosciences-Immunocytometry Systems, San Jose, CA, USA) was used for data collection, and the data were analyzed using CellQuest software (BD Biosciences-Immunocytometry Systems).
Decoy receptor of IL-21
The primers, 5 0 -TTCTAGCTACCAGCTGCAGGT-3 0 and 5 0 -TCCTGAAGTTCCTCATATTCA-3 0 , were used to produce a truncated IL-21R lacking the region from box 1 to the C-terminus. 8 All nucleotide sequences were confirmed by sequencing. Extracellular expression of this receptor was confirmed by flow cytometric analysis using anti-IL-21-receptor polyclonal Ab (R&D Systems, Minneapolis, MN, USA) and a secondary Ab conjugated with FITC (R&D Systems).
Retrovirus mediated transduction into BM
A retrovirus construct containing the decoy receptor of IL-21 was transfected into the packaging cell line, PLAT-E, and the viruses produced were transduced into prestimulated BM cells using Retronectin according to the manufacturer's instructions (Takara, Osaka, Japan). We used 5-15 Â 10 5 BM cells from 5-FU injected mice at the beginning of cultivation.
Carboxyfluorescein diacetate succinimidyl ester staining Splenocytes were stained with carboxyfluorescein diacetate succinimidyl ester (CFSE) for 15 min in phosphate-buffered saline, washed and injected into irradiated mice. Staining was carried out according to the manufacturer's instructions (Invitrogen-Molecular prove, Carlsbad, CA, USA). ELISA Enzyme linked immunosorbent assay kits for cytokines, IFN-g and IL-4 were purchased from BD Bioscience or R&D Systems. Concentrations were determined according to the manufacturer's instructions.
Statistical analysis
Kaplan-Meier plots were used to compare survival rates.
The log-rank test was used to evaluate P values. The Mann-Whitney U test was used to calculate P values for the GVHD clinical score. Statistical analyses were performed using ''Stat Mate ver. 6'' (ATMS, Tokyo, Japan).
Unless otherwise specified, all error bars in this study are s.e.m. and transplanted into irradiated Balb/c mice. Recipients of BM and SPs from WT mice became ill after 3-4 weeks and suffered from diarrhea, ruffled hair, a hunched posture and diminished body weight. In contrast, mice transplanted from IL-21R KO mice showed attenuated GVHD symptoms and survived longer (Figure 1a , P ¼ 0.0003, log-rank test). Strikingly, no mouse receiving the WT-SPs group survived more than 4 months, whereas 40% of the mice receiving the IL-21R KO SPs survived for 4 months or longer. Consistent with this, clinical GVHD scores in mice transplanted from IL-21R KO-SPs were significantly less than those in controls (Figure 1b) . In both groups, approximately 85% engraftment in peripheral blood was achieved, indicating that the difference was not attributable to a difference in engraftment.
Results
IL-21R
KO-SP causes attenuated GVHD when combined with KO-BM In the preceding experiments (Figures 1a and b) , we used unfractionated WT-BM, which presumably contained IL-21R-expressing T cells that could respond to IL-21. To eliminate contaminating IL-21R þ / þ T cells from BM, we next used BM from IL-21R KO mice, in combination with SPs from either WT or KO mice. This resulted in enhanced differences in survival between the groups receiving the WT vs IL-21R KO-SP after two months: 0 vs 60% (Figure 1c , P ¼ 0.0001 by log-rank test), respectively, confirming the former results (Figures 1a   and b) and a critical role for IL-21 in GVHD. Consistent with this, clinical GVHD scores in the WT-SP group were higher than those in the IL-21R KO-SP group (Figure 1d ).
CD4/CD8 proliferation and serum cytokine levels
To investigate the mechanisms underlying the attenuated GVHD in IL-21R KO-SP transplanted mice, we first counted the number of CD4 and CD8 cells in the spleens 14 days after transplantation. In both IL-21R KO-SP and WT-SP transplanted mice, both cell types were similar in number (Table 1) . Next, SPs were stained with carboxyfluorescein diacetate succinimidyl ester to determine their proliferation in mice after transplantation. Both CD4 and CD8 cells from either WT-SP or IL-21R KO-SP transplanted mice showed similar proliferation profiles at day 3 ( Figure 2a ). Serum concentrations of IFN-g and IL-4 at day 14 (Figure 2b ), those at day 6 (Figure 2c) , and IFN-g and IL-4 produced by recipients' SPs stimulated with allogeneic SPs in vitro were comparable between two groups (Figure 2d ).
Effects of additional CD4 or CD8 cells on survival
To investigate whether CD4 þ T cells are more important for GVHD than CD8 þ T cells in our system, we added either WT-CD4
cells onto the result-predictable transplantation with IL-21R KO-BM and IL-21R KO-SP (Figure 1c). The addition of WT-CD4
þ cells resulted in a significantly worse survival than seen with the addition of IL-21R KO-CD4 þ cells (Figure 3a , P ¼ 0.0024, log-rank method). In contrast to this, the difference between WT-CD8 þ and IL-21R KO-CD8 þ T cells did not reach statistical significance (Figure 3b , P ¼ 0.09, log-rank method), although they have similar tendency, suggesting that WT-CD4 þ rather than WT-CD8 þ cells is more important for GVHD, at least in our conditions.
A decoy receptor of IL-21 ameliorates GVHD
To develop a treatment or prophylaxis model in mice and exclude the possibility that the ameliorated GVHD is due to an intrinsic defect in the IL-21R KO-SPs, we designed a decoy receptor of IL-21, which contains its signal sequence, extracellular domain and transmembrane domain, but a truncated intracellular domain. The cDNA encoding this truncated IL-21R was produced by PCR, sequenced, and its extracellular expression in 293 cells was confirmed by flow cytometric analysis using an anti-IL-21R Ab (Figure 4a) . In 293 cells, we confirmed that the IL-21R decoy reduced IL-21 concentration in the medium in vitro (Figure 4b) . Using retroviral transduction, we expressed the decoy receptor in IL-21R KO-BM cells and transplanted them concomitantly with WT-SPs. We carried out three independent experiments and evaluated the survival. Two weeks after transplantation, transduction efficiencies were determined in peripheral blood by measuring green fluorescent protein-positive cells, and were found to be approximately 30-70% (Figure 4c) . In an additional experiment, in which transduction efficiency was 40%, the serum concentration of IL-21 was not detectable in decoy receptor transduced BM recipients, whereas those trans- (Figure 4e , P ¼ 0.003, log-rank test), suggesting that blockade of the IL-21 signal might be an effective treatment or prophylaxis for GVHD. These results are consistent with the results shown above (Figure 1) , and support the hypothesis that IL-21 promotes GVHD.
The attenuated GVHD appeared to be independent of cytotoxic molecules The significance of cytotoxic molecules such as perforin and granzyme B in GVHD has been reported. 24 To investigate the relationship between these molecules and the attenuated GVHD, we sought to see the levels of expression of these molecules in CD4 þ and CD8 þ T cells. No clear difference between WT-SP and IL-21R KO-SP transplanted mice was detected (Figure 5a ). Moreover, we used a combination of IL-21 decoy receptor and perforin-deficient mice. The IL-21 decoy receptor-transduced BM improved survival of recipients with SPs from perforin-deficient mice, suggesting that the mechanism of the attenuated GVHD is primarily independent of perforin in vivo (Figure 5b) . The Fas/FasL system is another cytotoxic molecule and was reported to be important for GVHD rather than GVL. 25, 26 To investigate a possible role for Fas/FasL in the attenuated GVHD, we analyzed the effect of IL-21 decoy receptor transduced BM on survival of recipients with SPs from FasL deficient (gld/gld) mice and found enhanced survival, suggesting that the mechanism of the attenuated GVHD is also primarily independent of Fas/FasL (Figure 5c ).
Discussion
Here, we report that IL-21 is critical for GVHD. SPs from IL-21R À/À (KO) mice induced less severe GVHD than those from WT mice. Moreover, a decoy receptor for IL-21 attenuates GVHD and prolongs survival, confirming the former experiments with KO mice and suggesting that a possible clinical application of blocking IL-21 for the treatment or prophylaxis of GVHD.
Serum IFN-g and IL-4 concentrations, CD4/CD8 T-cell proliferation at day 3 after transplantation, and the number of CD4 þ /CD8 þ T cells in spleens of recipients at day 14 after transplantation, all appeared to be comparable between two groups at least under the conditions we have tested. In addition, the decoy IL-21R also ameliorated GVHD induced by FasL-deficient and perforin-deficient SPs, suggesting that Fas/FasL and perforin are not crucial for the mechanism of the attenuated GVHD by IL-21R KO SPs. However, we could not rule out the possibility that the other transplantation conditions might make the difference more profound and lead to interpretation of the mechanisms. Results of additional CD4 þ /CD8 þ experiments suggested the importance of CD4 þ cells. We are now investigating the process by using other transplantation models, such as purified CD4 þ T-cell transplantation. Although we have shown that IL-21 is critical for GVHD in two different systems using both IL-21R KO mice and decoy receptor for IL-21, the molecular mechanisms by which blocking IL-21 attenuates GVHD are not clear at this point.
As the transplantation model we used is an MHCmismatch CD4 þ cell-mediated GVHD, a role for IL-21 in both CD8
þ cell-mediated GVHD and MHC-matched GVHD is an area for future investigation.
Here, we opened a new insight for mechanisms of GVHD. These results would help in understanding the mechanisms of GVHD and in developing a treatment for GVHD. In fact, we could demonstrate that IL-21 blockade is a potentially novel approach for the treatment or prophylaxis of GVHD in mouse model. Further in vivo and in vitro studies, including humans, are required to potentially translate these results from mouse models to human diseases.
Conflict of interest
Drs Katsutoshi Ozaki and Warren J Leonard are inventors on patents and patent applications related to IL-21. . Filled squares and filled triangles indicate transplantations with empty-vector transduced BM (n ¼ 9) or decoy-receptor transduced BM (n ¼ 9), respectively. The combined results of two independent experiments are shown. P-value was calculated by the log-rank method. Transduction efficiencies two weeks after transplantation in peripheral blood were around 30-70% like Figure 4c 
